Quick Answer
Peppermint Hypertension Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: P P P P P Table 2 In terms of pain management, peppermint oil significantly reduced pain scores from 6.18 ± 0.94 to 4.59 ± 0.89 (< 0.001), whereas the placebo group showed no significant improvement, with scores changing from 6.09 ± 0.96 to 5.98 ± 0.95 (= 0.132).
Key Takeaways
- 01P P P P P Table 2 In terms of pain management, peppermint oil significantly reduced pain scores from 6.18 ± 0.94 to 4.59 ± 0.89 (< 0.001), whereas the placebo group showed no significant improvement, with scores changing from 6.09 ± 0.96 to 5.98 ± 0.95 (= 0.132). [Sharafi Hossein (2026)]
- 02Compared to placebo, peppermint oil significantly reduced systolic blood pressure, heart rate, pain, anxiety, and stress. [Sharafi Hossein (2026)]
- 03Notably, 1 study found that inhalation of peppermint essential oil does not significantly affect systolic blood pressure.The reason for this discrepancy can be attributed to the methods of administration and the contexts in which they are applied across different groups of individuals. [Sharafi Hossein (2026)]
- 04The interplay between the “brain-heart axis” is particularly pivotal in determining cardiovascular outcomes, especially among individuals with pre-existing cardiovascular conditions.Moreover, anxiety and depression are notably prevalent among patients experiencing ACS, with over half of this demographic exhibiting such psychological conditions. [Sharafi Hossein (2026)]
The current Migaku evidence database contains 1 reusable source document for Peppermint Hypertension Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- P P P P P Table 2 In terms of pain management, peppermint oil significantly reduced pain scores from 6.18 ± 0.94 to 4.59 ± 0.89 (< 0.001), whereas the placebo group showed no significant improvement, with scores changing from 6.09 ± 0.96 to 5.98 ± 0.95 (= 0.132). [Sharafi Hossein (2026); evidence level 2]
- Compared to placebo, peppermint oil significantly reduced systolic blood pressure, heart rate, pain, anxiety, and stress. [Sharafi Hossein (2026); evidence level 2]
- Notably, 1 study found that inhalation of peppermint essential oil does not significantly affect systolic blood pressure.The reason for this discrepancy can be attributed to the methods of administration and the contexts in which they are applied across different groups of individuals. [Sharafi Hossein (2026); evidence level 2]
- The interplay between the “brain-heart axis” is particularly pivotal in determining cardiovascular outcomes, especially among individuals with pre-existing cardiovascular conditions.Moreover, anxiety and depression are notably prevalent among patients experiencing ACS, with over half of this demographic exhibiting such psychological conditions. [Sharafi Hossein (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources